Ethambutol

Suppliers

Names

[ CAS No. ]:
74-55-5

[ Name ]:
Ethambutol

[Synonym ]:
(S,S)-Et,Et-FerroTANE
(+)-1,1'-BIS[(2R,4R)-2,4-DIETHYLPHOSPHONATO]FERROCENE
R,R-Et-FerroTANE
(S,S)-2,2'-(ethylenediimino)di-1-butanol
(R,R)-ET-FERROTANE(TM)
(+)-1,1'-BIS((2R,4R)-2,4-DIETHYLPHOSPHOTANO)FERROCENE
(S,S)-1-[1-(DI-TERT-BUTYLPHOSPHINO)ETHYL]-2-(DIPHENYLPHOSPHINO)FERROCENE
Et-Ferrotane
1-Butanol, 2,2'-(1,2-ethanediyldiimino)bis-
Ethambutol
(S)-(+)-1-[(R)-2-(DIPHENYLPHOSPHINO)FERROCENYL]ETHYLDI-T-BUTYLPHOSPHINE
2,2'-(1,2-Ethanediyldiimino)di(1-butanol)
JOSIPHOS SL-J002-2

Chemical & Physical Properties

[ Density]:
1.0±0.1 g/cm3

[ Boiling Point ]:
345.3±22.0 °C at 760 mmHg

[ Melting Point ]:
199 - 204ºC

[ Molecular Formula ]:
C10H24N2O2

[ Molecular Weight ]:
204.310

[ Flash Point ]:
113.7±12.9 °C

[ Exact Mass ]:
204.183777

[ PSA ]:
64.52000

[ LogP ]:
-0.05

[ Vapour Pressure ]:
0.0±1.7 mmHg at 25°C

[ Index of Refraction ]:
1.478

[ Storage condition ]:
2-8℃

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
EL3640000
CHEMICAL NAME :
1-Butanol, 2,2'-(1,2-ethanediyldiimino)bis-, (R)-
CAS REGISTRY NUMBER :
74-55-5
LAST UPDATED :
199706
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C10-H24-N2-O2
MOLECULAR WEIGHT :
204.36
WISWESSER LINE NOTATION :
Q1Y2&M2MY2&1Q -D

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
900 mg/kg/60D-I
TOXIC EFFECTS :
Liver - jaundice, cholestatic
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 292,866,1986
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
600 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - structural change in nerve or sheath Behavioral - changes in motor activity (specific assay) Kidney, Ureter, Bladder - other changes in urine composition
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 2,1105,1976
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
1200 mg/kg
TOXIC EFFECTS :
Skin and Appendages - dermatitis, other (after systemic exposure) Immunological Including Allergic - anaphylaxis
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 2,1105,1976
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
8700 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
DPHFAK Dissertationes Pharmaceuticae et Pharmacologicae. (Warsaw, Poland) V.18-24, 1966-72. For publisher information, see PJPPAA. Volume(issue)/page/year: 23,463,1971
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1075 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
DPHFAK Dissertationes Pharmaceuticae et Pharmacologicae. (Warsaw, Poland) V.18-24, 1966-72. For publisher information, see PJPPAA. Volume(issue)/page/year: 23,463,1971
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
240 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
DPHFAK Dissertationes Pharmaceuticae et Pharmacologicae. (Warsaw, Poland) V.18-24, 1966-72. For publisher information, see PJPPAA. Volume(issue)/page/year: 23,463,1971
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
890 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - other changes
REFERENCE :
NYKZAU Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- Volume(issue)/page/year: 63(3),114S,1967
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
350 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - other changes
REFERENCE :
NYKZAU Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- Volume(issue)/page/year: 63(3),114S,1967

Safety Information

[ HS Code ]:
2922191000

Synthetic Route

Precursor & DownStream

Precursor

  • (2S,2'S)-(ethylenediimino)-bis(3-buten-1-yl)benzyl ether
  • (2S,2'S)-(oxalamido)-bis(3-buten-1-yl)benzyl ether
  • N,N'-bis[(2S)-1-[tert-butyl(dimethyl)silyl]oxybutan-2-yl]oxamide
  • (-)-(S)-N,N'-Bis-(2-hydroxy-1-aethyl-aethyl)-oxalsaeurediamid
  • 2,2'-bis(4-ethyloxazoline)
  • N,N'-bis-((S)-1-chloromethyl-propyl)-oxalamide
  • Isobutanol-2-amine
  • dichloroethane
  • 1,2-Dibromoethane

DownStream

  • 1,2-Ethanediamine

Customs

[ HS Code ]: 2922191000


Related Compounds

  • Ethambutol
  • ethambutol
  • ethambutol
  • ethambutol
  • Ethambutol-d4
  • EthaMbutol-d8
  • 4,4-difluoro-1-(1-phenyl-1H-pyrazol-4-yl)cyclohexan-1-amine
  • [1-(2-Phenoxyphenyl)cyclopropyl]methanol
  • 2-Methyl-2-(2-phenoxyphenyl)propan-1-amine
  • 4,4-difluoro-1-(3-phenyl-1H-pyrazol-4-yl)cyclohexan-1-amine
  • Methyl 3-(4,5-difluoro-2-methoxyphenyl)-3-oxopropanoate
  • 3-(2,6-Difluorophenyl)-2,2-dimethylcyclopropane-1-carboxylic acid
  • 5-Methoxy-5-oxo-3-(pyridin-4-yl)pentanoic acid
  • (1S)-3-amino-1-(5-methyl-2-nitrophenyl)propan-1-ol
  • 3-(5-Methyl-2-nitrophenyl)azetidine
  • 1-[2-(Pyrazin-2-yl)propan-2-yl]cyclopropan-1-amine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.